Counterfeit drugs can contain wrong doses, harmful fillers, or no active ingredient at all
In Rio de Janeiro, a 37-year-old woman was hospitalized in serious condition after injecting what she believed to be Ozempic — a reminder that the collision between surging demand and unregulated markets carries consequences measured not in reais, but in human health. As the appetite for the drug has grown beyond its original diabetic purpose into a cultural weight-loss phenomenon, so too has the shadow market that exploits it. Novo Nordisk and Brazil's ANVISA have responded with public guidance, but the deeper question lingers: when desire outpaces access, who bears the cost?
- A woman in Rio de Janeiro was hospitalized in serious condition after injecting a counterfeit version of Ozempic, confirming that the fake drug crisis has already caused real, severe harm.
- Ozempic's explosive off-label popularity as a weight-loss drug has created a fertile black market, with counterfeits circulating through social media, messaging apps, and unlicensed online sellers.
- Fake versions may contain wrong doses, dangerous fillers, or no active ingredient at all — making every unauthorized purchase a gamble with unpredictable medical consequences.
- Novo Nordisk and ANVISA have issued detailed guidance: check packaging integrity, confirm the light blue pen with gray button, buy only from licensed retailers, and verify pricing falls within the official R$929–R$1,280.87 range.
- Anyone who suspects they have purchased a counterfeit is urged not to use it and to report it through Novo Nordisk's dedicated hotline, website, or email — channels the company has specifically staffed in response to the crisis.
A 37-year-old woman in Rio de Janeiro was hospitalized in serious condition after injecting what she believed was Ozempic. On October 21st, Novo Nordisk confirmed that counterfeit versions of the drug are actively circulating in Brazil and issued a public alert.
Ozempic was developed to treat type 2 diabetes, but its growing reputation as a weight-loss medication has driven demand far beyond official supply — and that gap has been filled, in part, by counterfeiters. Fake drugs can contain incorrect doses, harmful substances, or no active ingredient at all, turning what feels like a shortcut into a serious medical risk.
Both Novo Nordisk and ANVISA have outlined how to identify a legitimate product. The packaging should be clean and clearly printed in Portuguese, without damage or foreign-language text. Authentic Ozempic comes only as a pre-filled injection pen — light blue with a gray button — never as a vial, capsule, pellet, or strip. Counterfeiters have been known to swap labels between different Novo Nordisk products, so the pen's physical appearance is a critical check.
Where and at what price a product is purchased are equally important signals. ANVISA licenses specific retailers and websites; sellers operating primarily through social media or messaging platforms are a red flag. The official price range set by Brazil's medicines regulatory chamber sits between R$929 and R$1,280.87 — anything significantly cheaper should raise immediate suspicion.
Anyone who believes they have purchased a counterfeit should not use it and can report it to Novo Nordisk via their toll-free line, customer service website, or dedicated email. The hospitalization in Rio is a stark reminder that behind the cultural phenomenon of this drug lies a medical reality — and the consequences of a fake can be severe.
A 37-year-old woman in Rio de Janeiro ended up in the hospital in serious condition after injecting what she believed was Ozempic. On Monday, October 21st, Novo Nordisk—the pharmaceutical company that manufactures the drug—confirmed that counterfeit versions are circulating and issued a public alert with specific warning signs.
The stakes are high. Ozempic is prescribed for type 2 diabetes, but it has become increasingly popular as an off-label weight-loss medication, which has only amplified demand and, with it, the market for fakes. When people buy medications through unofficial channels, they're not just risking their money. They're risking their bodies. Counterfeit drugs can contain wrong doses, harmful fillers, or no active ingredient at all—any of which can cause serious harm.
Both Novo Nordisk and Brazil's National Health Surveillance Agency (ANVISA) have published guidance on how to spot a fake. The first place to look is the box itself. Legitimate Ozempic comes in packaging that is clean and clearly printed. Counterfeits often have visible damage, text in foreign languages, or pharmaceutical presentation that doesn't match the official version. The information on the label may be incomplete or wrong.
The delivery method matters too. Real Ozempic comes only as a pre-filled injection pen. If you encounter it in any other form—as a vial, oral capsule, absorbable pellets, strips, or chips—it is not legitimate Ozempic. The pen itself has a specific appearance: light blue color with a gray injection button. Other Novo Nordisk products, like Fiasp insulin, come in darker blue pens with orange buttons. Counterfeiters have been known to swap labels between different products, so the pen's actual color and button are critical identifiers.
Where you buy matters as much as what you're buying. ANVISA licenses certain websites and retailers to sell medications legally. Avoid any seller using the brand name in their web address, or any that primarily operate through social media apps and messaging platforms. These are red flags. Price is another signal. The Brazilian Medicines Market Regulation Chamber (CMED) has set the official price range for Ozempic between 929 and 1,280.87 Brazilian reais. If you find it significantly cheaper, the product is almost certainly not authentic.
If someone suspects they have purchased counterfeit medication, they should not use it. Novo Nordisk has set up multiple ways to report and get help: a customer service website, a toll-free phone line at 0800 014 44 88, and an email address at sac.br@novonordisk.com. The company is taking the problem seriously enough to staff these channels specifically for this crisis.
What began as a diabetes treatment has become a cultural phenomenon, and that popularity has created an opening for criminals. The woman hospitalized in Rio is a reminder that the consequences are not abstract. They are real, they are medical, and they can be severe.
Citações Notáveis
In case of purchase of suspicious medication, it should not be used. Customers should contact customer service through the website, phone (0800 014 44 88), or email (sac.br@novonordisk.com).— Novo Nordisk advisory
A Conversa do Hearth Outra perspectiva sobre a história
Why is Ozempic specifically being counterfeited so much right now? It's not like it's a new drug.
It's new in the way people want it. For decades it was a diabetes medication that diabetics took. Then people started using it off-label for weight loss, and suddenly demand exploded. That demand creates opportunity for counterfeiters.
So the woman in Rio—do we know what was actually in the fake she used?
The source doesn't say. We know she was hospitalized in serious condition, but the specifics of what the counterfeit contained or what harm it caused aren't detailed. That's part of what makes it frightening. You don't know what you're getting.
The pen color thing seems almost too simple to be a reliable check.
It is simple, which is why it works. Counterfeiters can fake packaging, they can print labels, but getting the exact shade of blue and the button color right requires precision. It's a detail that separates the real from the fake more reliably than most people would expect.
What about people who buy from social media? Are they knowingly breaking the law, or are they just not thinking about it?
Probably both. Some people know they're buying outside official channels and don't care. Others genuinely don't realize that a seller operating through Instagram or WhatsApp isn't licensed. They see a price, they see what looks like a product, and they buy. The burden falls on them to verify, but most people don't know how.
If someone has already used a counterfeit dose, what should they do?
The guidance says don't use it going forward and contact Novo Nordisk. But the real question—what to do if you've already been exposed—that's not answered in the alert. That's a gap.